Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01059630
Brief Title: A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)

First Submitted : January 28, 2010
First Submitted that Met QC Criteria : January 28, 2010
First Posted : February 1, 2010 (Estimate)

Results First Submitted : September 27, 2016
Results First Submitted that Met QC Criteria : September 27, 2016
Results First Posted : November 17, 2016 (Estimate)

Certification/Extension First Submitted : September 1, 2015
Certification/Extension First Submitted that Met QC Criteria : November 8, 2015
Certification/Extension First Posted : December 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : December 20, 2019
Last Update Posted : January 13, 2020